The β-hydroxybutyrylation of Zyxin ameliorates pulmonary fibrosis by inhibiting lung fibroblast activation through the PI3K/AKT pathway

Li Qiu, Haoying Huang, Sen Li, Haixia Chen, Xiaohui Wang · 2026

Read The β-hydroxybutyrylation of Zyxin ameliorates pulmonary fibrosis by inhibiting lung fibroblast activation through the PI3K/AKT pathway by Li Qiu, Haoying Huang, Sen Li, Haixia Chen, Xiaohui Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13479915.txt.

Description

Li Qiu and four colleagues showed in 2026 how a tag on the protein Zyxin eases lung scarring in mice. Idiopathic pulmonary fibrosis is a lethal lung disease with murky causes, driven by overactive lung cells laying down excess scar tissue.

In bleomycin-injured mice, the Zyxin tag known as Kbhb fell sharply, while adding beta-hydroxybutyrate restored the tag and softened fibrosis. Gene and protein checks pointed to the PI3K/AKT pathway, with the tag lost at one Zyxin site in diseased mice. Removing Zyxin or giving the supplement cut scarring, collagen buildup, and death, marking this tag as a fresh treatment lead.

Catalog record

CREATORLi Qiu, Haoying Huang, Sen Li, Haixia Chen, Xiaohui Wang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE48 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13479915

Browse the full library · About the Tower of Babel